Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of Postoperative Opioid Dispensing among Medicaid Beneficiaries, 2016-2017 and 2021-2022.

The journal of pain·2026
Same author

Tuberculosis before and during COVID-19 Pandemic, United States, 2010-2023.

Emerging infectious diseases·2026
Same author

Opportunities in stroke care at safety net hospitals: A socioecological perspective.

Equity neuroscience·2025
Same author

Characteristics of Tuberculosis Tests Performed during Postimport Quarantine of Nonhuman Primates, United States, 2021 to 2024.

Journal of the American Association for Laboratory Animal Science : JAALAS·2025
Same author

Characteristics of noncancer chronic pain-associated ambulatory care visits, 2018-2019.

Pain medicine (Malden, Mass.)·2025
Same author

Awareness of and Beliefs About Naloxone Among Adults.

JAMA health forum·2025
Same journal

QuickStats: Percentage of Births in Which Women Received Prenatal Care in the First Trimester of Pregnancy, by State - United States, 2024.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Legionellosis Outbreaks Associated with Two Hotels - U.S. Virgin Islands, October 2024-April 2025.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Alpha-gal Immunoglobulin E Seroprevalence Among Blood Donors - 10 States, 2024-2025.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Notes from the Field: Drug Overdose Deaths in Hotels and Motels - United States, 2022-2024.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Emergency Department Visits for Suspected Suicide Attempts - United States, 2021-2025.

MMWR. Morbidity and mortality weekly report·2026
Same journal

Notes from the Field: Initial Public Health Response to a Measles Outbreak in a Close-Knit West Texas Community - January-February 2025.

MMWR. Morbidity and mortality weekly report·2026
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.8K

Tuberculosis - United States, 2016.

Kristine M Schmit, Zimy Wansaula, Robert Pratt

    MMWR. Morbidity and Mortality Weekly Report
    |March 24, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Tuberculosis (TB) cases in the US reached a record low in 2016. However, current decline rates are too slow for elimination this century, necessitating enhanced latent TB infection (LTBI) treatment.

    More Related Videos

    Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
    08:58

    Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

    Published on: April 30, 2019

    9.5K
    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
    13:47

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

    Published on: May 19, 2020

    3.9K

    Related Experiment Videos

    Last Updated: Mar 5, 2026

    Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
    15:57

    Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

    Published on: July 11, 2015

    12.8K
    Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
    08:58

    Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

    Published on: April 30, 2019

    9.5K
    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
    13:47

    Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

    Published on: May 19, 2020

    3.9K

    Area of Science:

    • Public Health
    • Epidemiology
    • Infectious Disease

    Background:

    • Tuberculosis (TB) remains a significant public health concern in the United States.
    • While reported cases have decreased, the rate of decline is insufficient for achieving elimination goals.
    • Existing strategies focus on active TB disease, but latent infection requires more attention.

    Purpose of the Study:

    • To analyze the latest trends in US tuberculosis cases.
    • To evaluate the progress towards TB elimination in the United States.
    • To highlight the need for intensified efforts in treating latent TB infection (LTBI).

    Main Methods:

    • Analysis of provisional case counts for tuberculosis in the United States for 2016.
    • Comparison of 2016 data with previous years to determine trends and rates of decline.
    • Epidemiologic modeling to project future TB elimination timelines based on current trends.

    Main Results:

    • A record low of 9,287 new tuberculosis cases were reported in the US in 2016, a 2.7% decrease from 2015.
    • The TB incidence rate decreased to 2.9 cases per 100,000 persons.
    • Modeling indicates that at the current rate of decline, US TB elimination will not be achieved this century.

    Conclusions:

    • Continued efforts to identify and treat active TB disease are essential.
    • Increased measures to identify and treat latent TB infection (LTBI) in high-risk populations are crucial.
    • Accelerating progress towards TB elimination requires a dual approach targeting both active and latent TB.